Safe Pharmaceutical Research Institute Co., the Beijing-based drug developer and safety testing services provider, has finished a series C round, led by Legend Capital, the China-based venture capital firm formed by conglomerate Legend Holdings.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
